[FURL=https://www.industryarc.com/Report/19287/antibody-testing-market.html]Antibody Testing Market[/FURL] size is $1.17 billion in 2019, growing at a CAGR of 12.4% during the forecast period 2020-2025. The increased incidence of autoimmune disorders, and rise in the adoption of antibody testing is driving the market during the forecast period 2020-2025. Antibody testing helps to diagnose an autoimmune disorder or rule out other conditions with similar signs and symptoms. Furthermore, the antinuclear antibodies (ANA) are a group of autoantibodies produced by an individual’s immune system when it fails to adequately distinguish between “self” and “non-self” components. The ANA test detects the antibodies in the blood. ANA reacts with components of the body’s healthy cells and causes symptoms such as tissue and organ inflammation, joint and muscle pain and fatigue. ANA specifically targets substances found in the nucleus of the cell, hence the also named “antinuclear antibodies”.Download Sample Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=19287[/FURL]
Key Takeaways
ELISA technique accounts for largest market share in 2019 owing to its high sensitivity, specificity and compatibility with other methods. It is widely used to detect substances in the body such as the radioimmune assay (RIA) test, thereby propelling the Antibody Testing Market.
Research facilities hospitals and clinical laboratories dominated the Antibody Testing Market owing to the convenience and numerous tests being conducted by them.
In 2019, North America dominates the Antibody Testing Market owing to the increased health concern among the population here and availability of better health infrastructure.
Increase in the prevalence of autoimmune disorders such as rheumatoid arthritis, Systemic lupus Erythematosus, Scleroderma and others is a major factor driving the Antibody Testing Market during the forecast period 2020-2025.
Geography- Segment Analysis
By region, North America accounts for 33% of the Antibody Testing Market share in 2019. Increasing health concerns along with the growing demand for advanced tests and a better healthcare structure is a major factor boosting its market growth. In April 2020, BD medical company and BioMedomics a North California based clinical based company launched a rapid antibody test for the coronavirus, which can be used to detect if a person’s immune system has Covid-19 or has recovered from it.
Drivers –Antibody Testing Market
Increasing of Autoimmune Disease
Rise in Government Healthcare Protection
Antibody Testing top 10 companies are Abbott, Voxtur Bio, Invitrogen, Abcam, Biolegend, Research and Diagnostic System Inc., Novus Biologicals, Protein Technologies, Enzo Life Sciences Inc., and Abnova.
About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.